Spotitearly

04/16/2026

Our Beagles aren’t just best friends, they’re life-saving partners. By combining their natural superpower with our AI technology, we’re changing the future of early detection.
The mission is growing, and now you can be a part of it. Our Regulation A+ offering is officially open to new investors🤝
🔗 Tap the link in our bio to join the pack and see how we’re saving lives together!

04/14/2026

André Goy, Director of John Theurer Cancer Center at Hackensack University Medical Center at Hackensack Meridian Health, has been named to the 2026 NJBIZ Health Care Power List.
Dr. Goy leads New Jersey's largest cancer care program and recently launched a cancer risk and early detection program, the first of its kind in the state. In his NJBIZ profile, he highlighted the SpotitEarly collaboration:
"Almost two-thirds of cancer diagnoses have no screening test. At Hackensack Meridian John Theurer Cancer Center, we are deeply committed to early cancer detection, the ultimate way to improve patient outcomes. Partnering with SpotitEarly on this innovative breath test technology offers a potentially groundbreaking approach to screening and aligns perfectly with our mission to transform cancer care through proactive prevention."
We are proud to work alongside Dr. Goy, Dr. Elias Obeid, Lee S. Ifhar and the HMH team on the PINK Study, our 2,000-participant multicenter breast cancer detection trial.
Congratulations, Dr. Goy.

2026 NJBIZ Health Care Power List: Meet the professionals leading the industry that keeps New Jerseyans strong, active and full of life.

04/12/2026

is one of just ten members of the Alliance of Dedicated Cancer Centers. It is part of Temple Health, and its researchers have been awarded two Nobel Prizes. So when we talk about institutional validation, this is what it looks like.
For us, this is exactly the kind of validation that matters as we move toward commercialization. Because at the end of the day, building a world-class clinical evidence base is what will set us apart in the market.

04/08/2026

300 million scent receptors give our beagles the nose for molecules that slip past every machine humans have built.

That biology, a training program that starts almost at birth, and our LUCID AI platform, drives sensitivity and specificity above 90% when they screen breath samples in our lab.

Dr. Irit Gazit explains why the olfactory cortex alone takes up 30% of a dog’s brain and how that power translates into life-saving calls.

We unpack the science, and the daily work behind it, in our Knowledge Center article.

Read the full story:

https://www.spotitearly.com/post/the-science-behind-dogs-ability-to-detect-cancer-through-scent

Dogs possess an extraordinary sense of smell — capable of detecting volatile organic compounds linked to cancer at concentrations humans cannot perceive. This article will explain the biology of canine olfaction, the research behind scent-based cancer detection, and how SpotitEarly plans to train ...

04/04/2026

We’re on a mission to change how the world screens for cancer. While our clinical trials are currently ongoing to ensure the highest standards of validation, we’re already looking ahead to our planned U.S. launch by the end of 202🗓️🇺🇸
For those who want to be part of what comes next, our Regulation A+ offering is officially open to new investors 🤝

04/03/2026

SpotitEarly's podcast is live 🔥 "The Long Game: Voices from the Healthfront" launches with its first episode, Cancer, Nature, and the Future of Diagnostics.

Our first guest is Matthew Avery, a legal scholar and patent attorney at Baker Botts, and someone we have the pleasure of working with.
In this conversation, we covered:
▪️ The FDA's readiness and regulatory approach to animal-based diagnostics
▪️ The potential of AI and sensor technology to standardize dog-based disease detection
▪️ How biotech founders should think about their IP strategy

Thank you Matthew Avery and Shlomi Madar for a great conversation.


Listen and watch: 🎧 Spotify | Apple Podcasts | Amazon Music 🎬 YouTube

https://podcasts.apple.com/il/podcast/cancer-nature-and-the-future-of-diagnostics/id1889241957?i=1000758252913

https://music.amazon.com/podcasts/9b144a30-b01e-4a1d-932d-a5b0203e5ffb/episodes/80ffcae9-6626-49d6-9576-21b3eb48f154/the-long-game-voices-from-the-health-front-cancer-nature-and-the-future-of-diagnostics

Podcast Episode · The Long Game | Voices from the health front · 27 March · 31min

04/01/2026

Yesterday, our CEO Shlomi Madar Ph.D. attended the Founders & Funders: NYC VC Reverse Pitch at the Jay Conference building. The format was a refreshing flip on the usual pitch dynamic. Six VCs took the stage to pitch their firms and investment theses to a room full of founders: 🔹 Avantika Daing, ...

03/26/2026

Daily life of cancer sniffing dogs😎🐶
play > work > snack > nap > repeat

03/15/2026

Each year, the editorial team at Fierce Healthcare, one of the industry’s most respected publications, selects just 15 private companies that are truly redefining the future of health.
Being recognized as one of the most innovative companies in a $4 trillion industry is more than just an award. It’s a powerful signal that the world is paying attention to what we are building: a future where cancer is caught earlier, faster, and more accurately through the synergy of AI and nature🐾🧬
🔗 Visit the link in our bio to read the full story and learn how you can invest!

03/10/2026

We are officially Regulation A Qualified, which means our mission to revolutionize cancer screening is now open to everyone 🌍✨
By combining the world’s most advanced nose with cutting-edge AI, we’re building a future where early detection is simple, non-invasive, and accessible. And now, you can own a piece of it.
Whether you’re a dog lover, a tech enthusiast, or a believer in a healthier future, we belong together🤝
🔗 Tap the link in our bio to explore our offering and join the SpotItEarly pack!

03/05/2026

If saving lives is your mission and world-changing tech is your passion, you belong with us❤️
We’ve combined the natural power of a dog’s scent with cutting-edge AI to create a screening mission that actually works for the real world. Simple, non-invasive, and built to catch what others miss.
The doors are finally open to our community to own a pieceof this journey.
Join the revolution. Tap the link in our bio to learn more about our Regulation A+ offering🔗